` NEO (Neogenomics Inc) vs A (Agilent Technologies Inc) Comparison - Alpha Spread

NEO
vs
A

Over the past 12 months, NEO has underperformed A, delivering a return of -46% compared to the A's 11% drop.

Valuation Comparison

NEO Intrinsic Value
14.01 USD
Undervaluation 49%
Intrinsic Value
Price
A Intrinsic Value
118.92 USD
Undervaluation 1%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Neogenomics Inc
NASDAQ:NEO
7.13 USD
Agilent Technologies Inc
NYSE:A
117.58 USD

Financials Comparison

Growth Over Time
NEO vs A

Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Neogenomics Inc
Revenue
Agilent Technologies Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
NEO vs A

Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Neogenomics Inc
NASDAQ:NEO
Agilent Technologies Inc
NYSE:A
What is Free Cash Flow?

Gross Margin

NEO
44.3%
A
53.8%

Operating Margin

NEO
-12.7%
A
23.3%

Net Margin

NEO
-11.5%
A
17.6%

FCF Margin

NEO
-4.8%
A
17.9%

ROE

NEO
-8.6%
A
18.9%

ROA

NEO
-4.8%
A
10.1%

ROIC

NEO
-6.8%
A
13.9%

ROCE

NEO
-5.9%
A
16.2%

Stocks Performance

Stocks Performance
NEO vs A

Loading

Performance Gap
NEO vs A

Loading
NEO
A
Difference
www.alphaspread.com

Performance By Year
NEO vs A

Loading
Unlock Full Access to Alpha Spread
Create Free Account